Participant flow16

How many started, completed or left each group, period by period.

1 to 16 of 16

Period	Milestone	Group	Participants
Overall Study	STARTED	Combined Safety Lead-in	37
Overall Study	STARTED	Phase 3: Triplet Arm	224
Overall Study	STARTED	Phase 3: Doublet Arm	220
Overall Study	STARTED	Phase 3: Control Arm	221
Overall Study	Crossover Participants	Combined Safety Lead-in	0
Overall Study	Crossover Participants	Phase 3: Triplet Arm	0
Overall Study	Crossover Participants	Phase 3: Doublet Arm	0
Overall Study	Crossover Participants	Phase 3: Control Arm	3
Overall Study	COMPLETED	Combined Safety Lead-in	0
Overall Study	COMPLETED	Phase 3: Triplet Arm	0
Overall Study	COMPLETED	Phase 3: Doublet Arm	0
Overall Study	COMPLETED	Phase 3: Control Arm	0
Overall Study	NOT COMPLETED	Combined Safety Lead-in	37
Overall Study	NOT COMPLETED	Phase 3: Triplet Arm	224
Overall Study	NOT COMPLETED	Phase 3: Doublet Arm	220
Overall Study	NOT COMPLETED	Phase 3: Control Arm	221

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02928224/flow